Dihexa 5mg — Vial Spec, Reconstitution Math & COA
Dihexa 5mg is a specialized research compound supplied as a high-purity lyophilized solid for in vitro, cell culture, and preclinical laboratory investigations. This technical specification guide outlines the physical properties, reconstitution concentration mathematics, solvent compatibility, and lot-matched analytical verification protocols for evaluating Dihexa in controlled experimental environments.
Quick answer
Dihexa 5mg is a specialized research compound supplied as a high-purity lyophilized solid for in vitro, cell culture, and preclinical laboratory investigations. This technical specification guide outlines the physical properties, reconstitution concentration mathematics, solvent compatibility, and lot-matched analytical verification protocols for evaluating Dihexa in controlled experimental environments.
Key takeaways
- A 5mg vial of [Dihexa](/research-peptides/dihexa) contains precisely five milligrams of target analytical-grade oligopeptide derivative (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide), prepared as a lyophilized matrix under nitrogen headspace flush.
- [Dihexa](/research-peptides/dihexa) was originally developed in academic laboratory settings as a stable, low-molecular-weight analogue designed to cross bio-membranes while retaining potent neurotrophic signaling activity.
- Accurate concentration calculations are vital for ensuring reproducible pipetting volumes across multi-well plates or automated bio-assay systems.
- Because [Dihexa](/research-peptides/dihexa) is a hydrophobic peptide derivative, its dissolution dynamics differ significantly from highly hydrophilic, polar peptides.
Overview of Dihexa 5mg Research Vials and Laboratory Application
A 5mg vial of Dihexa contains precisely five milligrams of target analytical-grade oligopeptide derivative (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide), prepared as a lyophilized matrix under nitrogen headspace flush. In preclinical literature, Dihexa is classified as an orally active or synthetic small-molecule peptide derivative engineered to bind hepatocyte growth factor (HGF) and potentiate its high-affinity receptor, c-Met. Principal investigators and laboratory technicians select the 5mg packaging configuration when designing pilot assay series, microfluidic cell-culture runs, or short-term receptor binding protocols where container turnover must be minimized to avoid reagent degradation.
While PX1 Research maintains a diverse inventory across our all peptides catalog—including specialized formats like Dihexa Capsules 10mg for solid-state assay models—the 5mg lyophilized vial remains a standard benchmark format for liquid assay preparation. Preparing exact working concentrations from a 5mg mass requires precise volumetric measurement and solvent selection. Every 5mg vial distributed by PX1 Research is held to strict analytical standards, providing verified purity, known molecular mass, and zero fillers or unlisted stabilizing agents.
Chemical Structure, Receptor Kinetics, and Preclinical Research Focus
Dihexa was originally developed in academic laboratory settings as a stable, low-molecular-weight analogue designed to cross bio-membranes while retaining potent neurotrophic signaling activity. Preclinical in vitro assays demonstrate that Dihexa binds directly to HGF with picomolar affinity ($K_d \approx 65 \text{ pM}$). This binding event facilitates HGF dimerization and subsequent auto-phosphorylation of the c-Met receptor tyrosine kinase domain, triggering downstream intracellular cascades including the MAPK/ERK and PI3K/Akt signaling pathways.
In rodent cell culture models, activation of the HGF/c-Met axis by Dihexa has been observed to stimulate spinogenesis, synaptogenesis, and dendritic arborization at nanomolar concentrations. Researchers studying synaptic plasticity, neuronal repair mechanisms, and cellular trophic factors routinely compare Dihexa to other neuro-active research compounds. For example, comparative assays often evaluate Dihexa alongside Semax, Selank, and Noopept to measure differential impacts on neurotrophin expression, receptor phosphorylation, and electrophysiological synaptic response.
Reconstitution Mathematics for 5mg Dihexa Vials
Accurate concentration calculations are vital for ensuring reproducible pipetting volumes across multi-well plates or automated bio-assay systems. To calculate the final concentration ($C$) of a reconstituted 5mg vial, divide the total mass ($m = 5 \text{ mg}$) by the diluent volume ($V$ in mL). Researchers can utilize the automated reconstitution calculator to verify custom volumetric dilution protocols rapidly.
When adding 1.0 mL of liquid solvent to a 5mg vial, the resulting stock concentration is $5.0 \text{ mg/mL}$ ($5000 \text{ } \mu\text{g/mL}$). If an experiment requires a lower stock density to increase micro-pipetting accuracy for small-dose delivery, adding 2.0 mL yields a stock concentration of $2.5 \text{ mg/mL}$ ($2500 \text{ } \mu\text{g/mL}$). Reconstituting with 3.0 mL of diluent produces a final concentration of approximately $1.67 \text{ mg/mL}$ ($1666.7 \text{ } \mu\text{g/mL}$). For high-throughput automated liquid handlers, maintaining a standard stock concentration (such as 5.0 mg/mL) simplifies serial dilution math across 96-well microplate layouts.
Solvent Selection and Dissolution Parameters
Because Dihexa is a hydrophobic peptide derivative, its dissolution dynamics differ significantly from highly hydrophilic, polar peptides. Attempting direct dissolution of 5mg Dihexa into 100% aqueous media—such as unbuffered sterile water or standard phosphate-buffered saline (PBS)—may result in slow dissolution, incomplete solvation, or visible particulate suspension.
To achieve a crystal-clear, stable stock solution, laboratory protocols typically recommend initial solvation in a minimal volume of organic co-solvent, such as dimethyl sulfoxide (DMSO) or sterile laboratory-grade ethanol, prior to diluting with aqueous vehicles like bacteriostatic water (0.9% benzyl alcohol preserved). A common laboratory practice involves reconstituting 5mg of Dihexa in $100\text{ }\mu\text{L}$ to $200\text{ }\mu\text{L}$ of 99.9% analytical-grade DMSO, agitating gently until dissolved, and then bringing the total volume up to 1.0 mL or 2.0 mL with bacteriostatic water. This creates a stable co-solvent vehicle containing 5% to 10% DMSO, which is well-tolerated in most cellular assays and animal tissue models without precipitating the active compound.
Aliquot Management and Freeze-Thaw Degradation Mitigations
Repeated freeze-thaw cycles of reconstituted peptide solutions accelerate peptide bond cleavage, aggregation, and physical degradation. Once a 5mg Dihexa vial has been fully dissolved into a stock solution, establishing an aliquot workflow is critical for maintaining assay integrity over multi-week experimental timelines.
Researchers should sub-aliquot the primary stock solution into sterile, low-binding micro-centrifuge tubes at single-use volumes (e.g., $50\text{ }\mu\text{L}$ to $100\text{ }\mu\text{L}$ per tube). Each aliquot must be labeled with the compound batch number, reconstituted concentration, solvent composition, and date. Aliquots intended for short-term use (within 7 to 14 days) can be stored at $2^\circ\text{C}$ to $8^\circ\text{C}$, while long-term stock reserves should be stored in deep-freeze conditions at $-20^\circ\text{C}$ or $-80^\circ\text{C}$. Once an individual aliquot is thawed for an assay run, any remaining unused liquid should be discarded rather than re-frozen.
Analytical Quality Standards: HPLC, Mass Spectrometry, and COAs
To guarantee that experimental results are reflective of pure Dihexa kinetics rather than synthetic byproducts or salt impurities, every lot manufactured for PX1 Research undergoes stringent third-party testing. Analytical testing protocols mandate High-Performance Liquid Chromatography (HPLC) to verify chemical purity and Liquid Chromatography-Mass Spectrometry (LC-MS) to confirm exact identity and molecular mass.
PX1 Research enforces a strict requirement of $\ge 99.0\%$ purity by HPLC peak area integration for all Dihexa lots. Additionally, every batch undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to verify that bacterial endotoxin levels remain well below standard laboratory thresholds ($< 0.5 \text{ EU/mg}$). Researchers can inspect, download, and archive lot-matched documentation directly from our centralized COA repository by cross-referencing the lot number printed on the vial label.
Format Selection: 5mg Lyophilized Vials vs. Alternative Configurations
When designing experimental trials, laboratory procurement officers must choose between distinct preparation formats based on assay throughput, dosing equipment, and storage infrastructure. The 5mg lyophilized vial offers maximum flexibility for liquid handling systems, micro-injection setups, and customized solvent vehicle formulations.
For alternative laboratory models requiring solid-state administration, oral gavage assays, or standardized dry-mass handling, solid formats such as Dihexa Capsules 10mg provide pre-measured dry masses that eliminate liquid reconstitution steps. Laboratories conducting large-scale screen series or high-volume cell culture studies can also explore our wholesale program to secure larger batch quantities with identical lot-matched quality guarantees and batch consistency.
Lyophilized and Reconstituted Handling and Storage Guidelines
Proper physical storage conditions prevent pre-analytical degradation of Dihexa research compounds. Upon receipt from PX1 Research's climate-controlled distribution centers in California and Arizona, unopened lyophilized 5mg vials should be placed into cold storage immediately.
Unopened lyophilized vials remain stable at room temperature ($20^\circ\text{C}$ to $25^\circ\text{C}$) during transit, but should be stored at $2^\circ\text{C}$ to $8^\circ\text{C}$ for mid-term storage (up to 12 months) or at $-20^\circ\text{C}$ for extended preservation (up to 24 months). Vials must be protected from direct light exposure and high humidity. Before inserting a syringe needle or pipette tip into the vial stopper, the rubber septum should be sanitized using a sterile 70% isopropyl alcohol wipe. For additional background on related biochemical tools, visit our comprehensive research library.
Frequently Asked Questions
What is the exact mass contained in a Dihexa 5mg vial?
Each vial contains 5.0 milligrams of high-purity, lyophilized Dihexa powder, verified by mass spectrometry and HPLC analysis.
How do I calculate the concentration of Dihexa after adding 2 mL of solvent?
Dividing the 5mg total mass by 2.0 mL yields a final stock concentration of 2.5 mg/mL (2500 µg/mL). You can also use our online reconstitution calculator to verify custom dilution volumes.
Is Dihexa 5mg soluble in pure water?
Dihexa is a hydrophobic small-molecule derivative with low water solubility. Solvating first in a small volume of DMSO (e.g., 10% total volume) before adding bacteriostatic water yields optimal clarity and stability.
How is lot-matched quality verified for PX1 Research compounds?
Every lot is tested by independent ISO 17025 accredited laboratories using HPLC for purity analysis, LC-MS for structural confirmation, and LAL assays for endotoxin verification.
Where can I access the Certificate of Analysis (COA) for my Dihexa vial?
Lot-matched COA documentation is freely accessible on our online COA lookup page by typing in the specific batch number printed on your vial.
What is the proper storage temperature for unopened Dihexa 5mg vials?
Unopened lyophilized vials should be stored at 2°C to 8°C for up to 12 months, or frozen at -20°C for long-term storage up to 24 months.
How does Dihexa compare to other compounds studied for synaptogenesis?
In preclinical research, Dihexa targets the HGF/c-Met pathway with high affinity, whereas peptides like Semax and Selank act predominantly via neurotrophic factor elevation (BDNF/NGF) and GABAergic/monoaminergic modulation.
What are the shipping options for PX1 Research products?
PX1 Research provides same-day shipping on orders placed Monday through Friday before cut-off times, shipping directly from our USA distribution hubs in California and Arizona.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.